SCHEMBL4572832

SCHEMBL4572832

NC(=O)CN1CCc2ccc(F)cc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.68
▸ CHRM3 P20309 1/20 0.68
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ XIAP P98170 1/20 0.44
▸ NOTUM Q6P988 1/20 0.43
▸ SCD O00767 1/20 0.42
▸ DPP9 Q86TI2 1/20 0.42
▸ AR P10275 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CHRM4 P08173 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTR2A P28223 2/20 0.40
▸ HTR2C P28335 2/20 0.40
▸ HTR2B P41595 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5118232 0.88 NOTUM (0.54) CHRM2CHRM3HDAC1HDAC6NOTUM
SCHEMBL19173796 0.85 CHRM2 (0.58) CHRM2CHRM3HDAC1HDAC6DRD2
SCHEMBL17560529 0.83 CHRM2 (0.48) CHRM2CHRM3ALDH1A1MAPTCHRM4
SCHEMBL17571924 0.82 CHRM2 (0.47) CHRM2CHRM3HDAC1HDAC6DRD2
SCHEMBL29930800 0.81 CHRM2 (1.00) CHRM2CHRM3HDAC1HDAC6DRD2
SCHEMBL12656515 0.79 HDAC1 (0.56) CHRM2CHRM3HDAC1HDAC6NOTUM
SCHEMBL6025353 0.78 ALDH1A1 (0.62) CHRM2CHRM3DRD4ALDH1A1MAPT
SCHEMBL12749905 0.77 XIAP (0.49) CHRM2CHRM3HDAC1HDAC6XIAP
SCHEMBL17560591 0.77 DRD2 (0.49) CHRM2CHRM3DRD2DRD4ALDH1A1
SCHEMBL22225699 0.77 CHRM2 (0.58) CHRM2CHRM3HDAC1HDAC6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207683-A1 BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. 2008-08-28 — — US claimed
WO-2008100622-A2 BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. (US) 2008-08-21 — — WO claimed
US-20080207683-A1 BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. 2008-08-28 — — US disclosed
WO-2008100622-A2 BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. (US) 2008-08-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207683-A1 BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S CTSS, CTSK, CTSZ CHRM2 3963/4885CHRM3 3576/4885HDAC1 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback